Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Research
Biotech
Clinical Data
Venture Capital
Deals
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Cell & Gene Therapy
COVID-19
Emerging Biopharma
Podcasts
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Subscribe
What are you searching for?
Enclose phrases in quotes. Use a + to require a term in results and - to exclude terms.
Example: +water -Europe
Subscribe
Research
Biotech
Clinical Data
Venture Capital
Deals
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Cell & Gene Therapy
COVID-19
Emerging Biopharma
Podcasts
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
drug discovery
Biotech
Boehringer puts down $481M to pursue emerging cancer target
Boehringer has bet the money on an opportunity to seize the holy grail of immuno-oncology: turning cold tumors hot.
Nick Paul Taylor
Mar 28, 2023 8:00am
Paratus launches with $100M and a mission to 'embrace the bats'
Feb 27, 2023 9:00am
Flagship, Charles River ink drug discovery AI pact
Feb 16, 2023 11:59am
Schrödinger expands neuroscience work with BMS, Otsuka deals
Jan 9, 2023 10:43am
Roche offers up to $554 million in biobucks to in-need Kronos
Jan 9, 2023 7:00am
Belharra's wave catches Genentech in $130M launch
Jan 4, 2023 10:45am
